Skip to main content

Advertisement

SpringerLink
Log in

Mitogen-Activated Protein Kinases Pathways Mediate the Sunitinib-Induced Hypertrophy in Rat Cardiomyocyte H9c2 Cells

  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

Sunitinib (SUN) is a multi-targeted tyrosine kinase inhibitor used for the treatment of gastrointestinal stromal tumors and renal cell carcinoma. Cardiotoxicity has been reported as a significant side effect associated with the SUN treatment, yet the mechanism is poorly understood. The main purpose of this study was to investigate the potential effects of SUN on cardiac hypertrophic genes and the role of mitogen-activated protein kinases (MAPKs) signaling pathway in rat cardiomyocyte H9c2 cell line. In the present study, real-time quantitative polymerase chain reaction showed that the treatment of H9c2 cells with increasing concentrations of SUN (0, 1, 2.5, and 5 µM) significantly induced hypertrophic gene markers, such as brain natriuretic peptides (BNP) and myosin heavy chain (β-MHC and α-MHC) in concentration- and time-dependent manners. The onset of mRNA induction was observed as early as 9 h and remained elevated for at least 18 h after treatment with SUN 5 µM. At the protein level, Western blot analysis showed that SUN increased BNP and β-MHC, while it inhibited α-MHC protein levels in a concentration-dependent manner. These SUN-mediated effects were associated with increase in cell size and hypertrophy by approximately 70 % at the highest concentration, 5 µM. Importantly, inhibition of the MAPK signaling pathway using SB203580 (p38 MAPK inhibitor), U0126 (extracellular signal-regulated kinase inhibitor), and SP600125 (c-Jun NH2-terminal kinase inhibitor) significantly potentiated the SUN-induced BNP and β-MHC mRNA levels, but did alter the α-MHC level. Whereas at the protein level, MAPK inhibitors generally decreased the SUN-induced BNP, whereas only SB and U0 increased β-MHC protein levels with no effect on α-MHC, which were associated with a significant decrease in cell size. Together, these results indicate that SUN induced hypertrophic gene expression through MAPK-dependent mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Atkins, M., Jones, C. A., & Kirkpatrick, P. (2006). Sunitinib maleate. Nature Reviews Drug Discovery, 5, 279–280.

    Article  CAS  PubMed  Google Scholar 

  2. Faivre, S., Demetri, G., Sargent, W., & Raymond, E. (2007). Molecular basis for sunitinib efficacy and future clinical development. Nature Reviews Drug Discovery, 6, 734–745.

    Article  CAS  PubMed  Google Scholar 

  3. Kassem, M. G., Motiur Rahman, A. F., & Korashy, H. M. (2012). Sunitinib malate. Profiles of Drug Substances, Excipients, and Related Methodology, 37, 363–388.

  4. Rini, B. I. (2007). Sunitinib. Expert Opinion on Pharmacotherapy, 8, 2359–2369.

    Article  CAS  PubMed  Google Scholar 

  5. Cheng, A. L., Kang, Y. K., Lin, D. Y., Park, J. W., Kudo, M., Qin, S., et al. (2013). Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial. Journal of Clinical Oncology, 31, 4067–4075.

    Article  CAS  PubMed  Google Scholar 

  6. Waqar, S. N., Gopalan, P. K., Williams, K., Devarakonda, S., & Govindan, R. (2013). A phase I trial of sunitinib and rapamycin in patients with advanced non-small cell lung cancer. Chemotherapy, 59, 8–13.

    Article  CAS  PubMed  Google Scholar 

  7. Goodman, V. L., Rock, E. P., Dagher, R., Ramchandani, R. P., Abraham, S., Gobburu, J. V., et al. (2007). Approval summary: Sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma. Clinical Cancer Research, 13, 1367–1373.

    Article  CAS  PubMed  Google Scholar 

  8. Chu, T. F., Rupnick, M. A., Kerkela, R., Dallabrida, S. M., Zurakowski, D., Nguyen, L., et al. (2007). Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet, 370, 2011–2019.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Imig, J. D., Zhao, X., Capdevila, J. H., Morisseau, C., & Hammock, B. D. (2002). Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension, 39, 690–694.

    Article  CAS  PubMed  Google Scholar 

  10. Force, T., Krause, D. S., & Van Etten, R. A. (2007). Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nature Reviews Cancer, 7, 332–344.

    Article  CAS  PubMed  Google Scholar 

  11. Gustafsson, A. B., & Gottlieb, R. A. (2007). Bcl-2 family members and apoptosis, taken to heart. American Journal of Physiology Cell Physiology, 292, C45–C51.

    Article  CAS  PubMed  Google Scholar 

  12. Hasinoff, B. B., Patel, D., & O’Hara, K. A. (2008). Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib. Molecular Pharmacology, 74, 1722–1728.

    Article  CAS  PubMed  Google Scholar 

  13. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B. E., Karandikar, M., Berman, K., et al. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews, 22, 153–183.

    CAS  PubMed  Google Scholar 

  14. Liang, Q., & Molkentin, J. D. (2003). Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. Journal of Molecular and Cellular Cardiology, 35, 1385–1394.

    Article  CAS  PubMed  Google Scholar 

  15. Yin, H., Zhang, J., Lin, H., Wang, R., Qiao, Y., Wang, B., et al. (2008). p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia. Inflammation, 31, 65–73.

    Article  CAS  PubMed  Google Scholar 

  16. Zhang, W., Elimban, V., Nijjar, M. S., Gupta, S. K., & Dhalla, N. S. (2003). Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure. Experimental and Clinical Cardiology, 8, 173–183.

    PubMed Central  CAS  PubMed  Google Scholar 

  17. Barry, S. P., Davidson, S. M., & Townsend, P. A. (2008). Molecular regulation of cardiac hypertrophy. International Journal of Biochemistry and Cell Biology, 40, 2023–2039.

    Article  CAS  PubMed  Google Scholar 

  18. Lin, H., Xu, L., Liu, H., Sun, Q., Chen, Z., & Yuan, G. (2011). KLF4 promotes the odontoblastic differentiation of human dental pulp cells. Journal of Endodontics, 37, 948–954.

    Article  PubMed  Google Scholar 

  19. Chang, S. W., Lee, S. Y., Kum, K. Y., & Kim, E. C. (2014). Effects of ProRoot MTA, Bioaggregate, and Micromega MTA on odontoblastic differentiation in human dental pulp cells. Journal of Endodontics, 40, 113–118.

    Article  PubMed  Google Scholar 

  20. Kerkela, R., Ilves, M., Pikkarainen, S., Tokola, H., Ronkainen, V. P., Majalahti, T., et al. (2011). Key roles of endothelin-1 and p38 MAPK in the regulation of atrial stretch response. American Journal of Physiology Regulatory, Integrative and Comparative Physiology, 300, R140–R149.

    Article  CAS  PubMed  Google Scholar 

  21. Kerkela, R., Pikkarainen, S., Majalahti-Palviainen, T., Tokola, H., & Ruskoaho, H. (2002). Distinct roles of mitogen-activated protein kinase pathways in GATA-4 transcription factor-mediated regulation of B-type natriuretic peptide gene. Journal of Biological Chemistry, 277, 13752–13760.

    Article  CAS  PubMed  Google Scholar 

  22. Han, J., & Molkentin, J. D. (2000). Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends in Cardiovascular Medicine, 10, 19–22.

    Article  CAS  PubMed  Google Scholar 

  23. Yang, C. C., Ornatsky, O. I., McDermott, J. C., Cruz, T. F., & Prody, C. A. (1998). Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. Nucleic Acids Research, 26, 4771–4777.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Liang, Q., Wiese, R. J., Bueno, O. F., Dai, Y. S., Markham, B. E., & Molkentin, J. D. (2001). The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Molecular and Cellular Biology, 21, 7460–7469.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Korashy, H. M., & El-Kadi, A. O. (2008). Modulation of TCDD-mediated induction of cytochrome P450 1A1 by mercury, lead, and copper in human HepG2 cell line. Toxicology In Vitro, 22, 154–158.

    Article  CAS  PubMed  Google Scholar 

  26. Korashy, H. M., Maayah, Z. H., Abd-Allah, A. R., El-Kadi, A. O., & Alhaider, A. A. (2012). Camel milk triggers apoptotic signaling pathways in human hepatoma HepG2 and breast cancer MCF7 cell lines through transcriptional mechanism. Journal of biomedicine and biotechnology, 2012, 593195.

    PubMed Central  PubMed  Google Scholar 

  27. Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402–408.

    Article  CAS  PubMed  Google Scholar 

  28. Korashy, H. M., & El-Kadi, A. O. (2004). Differential effects of mercury, lead and copper on the constitutive and inducible expression of aryl hydrocarbon receptor (AHR)-regulated genes in cultured hepatoma Hepa 1c1c7 cells. Toxicology, 201, 153–172.

    Article  CAS  PubMed  Google Scholar 

  29. Lowry, O. H., Rosebrough, N. J., Farr, A. L., & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.

    CAS  PubMed  Google Scholar 

  30. Sambrook, J., Fritsch, E. F., & Maniatatis, T. (1989). In N. Ford (Ed.), Molecular cloning: A laboratory manual. Plainview, NY: Cold Spring Harbour Laboratory Press.

    Google Scholar 

  31. Korashy, H. M., & El-Kadi, A. O. (2006). The role of aryl hydrocarbon receptor and the reactive oxygen species in the modulation of glutathione transferase by heavy metals in murine hepatoma cell lines. Chemico-Biological Interactions, 162, 237–248.

    Article  CAS  PubMed  Google Scholar 

  32. Korashy, H. M., & El-Kadi, A. O. (2008). The role of redox-sensitive transcription factors NF-kappaB and AP-1 in the modulation of the Cyp1a1 gene by mercury, lead, and copper. Free Radical Biology and Medicine, 44, 795–806.

    Article  CAS  PubMed  Google Scholar 

  33. Maayah, Z. H., Ansari, M. A., El Gendy, M. A., Al-Arifi, M. N., & Korashy, H. M. (2014). Development of cardiac hypertrophy by sunitinib in vivo and in vitro rat cardiomyocytes is influenced by the aryl hydrocarbon receptor signaling pathway. Archives of Toxicology, 88, 725–738.

    CAS  PubMed  Google Scholar 

  34. Clark, J. E., Sarafraz, N., & Marber, M. S. (2007). Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. Pharmacology and Therapeutics, 116, 192–206.

    Article  CAS  PubMed  Google Scholar 

  35. Zhao, Y., Xue, T., Yang, X., Zhu, H., Ding, X., Lou, L., et al. (2010). Autophagy plays an important role in sunitinib-mediated cell death in H9c2 cardiac muscle cells. Toxicology and Applied Pharmacology, 248, 20–27.

    Article  CAS  PubMed  Google Scholar 

  36. Kimes, B. W., & Brandt, B. L. (1976). Properties of a clonal muscle cell line from rat heart. Experimental Cell Research, 98, 367–381.

    Article  CAS  PubMed  Google Scholar 

  37. Watkins, S. J., Borthwick, G. M., & Arthur, H. M. (2011). The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cellular and Developmental Biology Animal, 47, 125–131.

    Article  CAS  PubMed  Google Scholar 

  38. Chen, Q. M., Tu, V. C., Wu, Y., & Bahl, J. J. (2000). Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes. Archives of Biochemistry and Biophysics, 373, 242–248.

    Article  CAS  PubMed  Google Scholar 

  39. Zordoky, B. N., Aboutabl, M. E., & El-Kadi, A. O. (2008). Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats. Drug Metabolism and Disposition, 36, 2277–2286.

    Article  CAS  PubMed  Google Scholar 

  40. French, K. J., Coatney, R. W., Renninger, J. P., Hu, C. X., Gales, T. L., Zhao, S., et al. (2010). Differences in effects on myocardium and mitochondria by angiogenic inhibitors suggest separate mechanisms of cardiotoxicity. Toxicologic Pathology, 38, 691–702.

    Article  CAS  PubMed  Google Scholar 

  41. Reiser, P. J., Portman, M. A., Ning, X. H., & Schomisch Moravec, C. (2001). Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. American Journal of Physiology Heart and Circulatory Physiology, 280, H1814–H1820.

    CAS  PubMed  Google Scholar 

  42. Hydock, D. S., Wonders, K. Y., Schneider, C. M., & Hayward, R. (2009). Voluntary wheel running in rats receiving doxorubicin: effects on running activity and cardiac myosin heavy chain. Anticancer Research, 29, 4401–4407.

    CAS  PubMed  Google Scholar 

  43. Lee, H. S., Son, C. B., Shin, S. H., & Kim, Y. S. (2008). Clinical correlation between brain natriutetic peptide and anthracyclin-induced cardiac toxicity. Cancer Research and Treatment, 40, 121–126.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Jarolim, P. (2006). Serum biomarkers for heart failure. Cardiovascular Pathology, 15, 144–149.

    Article  CAS  PubMed  Google Scholar 

  45. Spallarossa, P., Altieri, P., Aloi, C., Garibaldi, S., Barisione, C., Ghigliotti, G., et al. (2009). Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2. American Journal of Physiology Heart and Circulatory Physiology, 297, H2169–H2181.

    Article  CAS  PubMed  Google Scholar 

  46. Guo, R. M., Xu, W. M., Lin, J. C., Mo, L. Q., Hua, X. X., Chen, P. X., et al. (2013). Activation of the p38 MAPK/NF-kappaB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells. Molecular Medicine Reports, 8, 603–608.

    PubMed  Google Scholar 

  47. Huang, X. Z., Li, Z. R., Zhu, L. B., Huang, H. Y., Hou, L. L., & Lin, J. (2014). Inhibition of p38 mitogen-activated protein kinase attenuates butyrate-induced intestinal barrier impairment in A Caco-2 cell monolayer model. Journal of pediatric Gastroenterology and Nutrition (in press).

  48. Chen, R., Li, X., Lu, S., Ma, T., Huang, X., Mylonakis, E., Liang, Y., & Xi, L. (2014). Role of extracellular signal-regulated kinases 1 and 2 and p38 mitogen-activated protein kinase pathways in regulating replication of Penicillium marneffei in human macrophages. Microbes and Infection, 16, 401–408.

  49. Choi, H., Nguyen, H.N., & Lamb, F.S. (2014). Inhibition of endocytosis exacerbates TNFalpha-induced endothelial dysfunction via enhanced JNK and p38 activation. American Journal of Physiology Heart Circulatory Physiology, 306, H1154–H1163.

  50. Park, G. B., Choi, Y., Kim, Y. S., Lee, H. K., Kim, D., & Hur, D. Y. (2014). ROS-mediated JNK/p38-MAPK activation regulates Bax translocation in Sorafenib-induced apoptosis of EBV-transformed B cells. International Journal of Oncology, 44, 977–985.

    CAS  PubMed  Google Scholar 

  51. Su, X., Wang, X., Zhang, K., Yang, S., Xue, Q., Wang, P., & Liu, Q. (2014). ERK inhibitor U0126 enhanced SDT-induced cytotoxicity of human leukemia U937 cells. General Physiology Biophysics (in press).

  52. Randhawa, H., Kibble, K., Zeng, H., Moyer, M. P., & Reindl, K. M. (2013). Activation of ERK signaling and induction of colon cancer cell death by piperlongumine. Toxicology In Vitro, 27, 1626–1633.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Qin, W., Liu, P., Zhang, R., Huang, S., Gao, X., Song, Z., Wang, R., Chen, L., Guo, B., & Lin, Z. (2014). JNK MAPK is involved in BMP-2-induced odontoblastic differentiation of human dental pulp cells. Connective Tissue Research, 55, 217–224.

Download references

Acknowledgments

This work is supported by the King Abdulaziz City for Science and Technology (KACST) Grant # A-S-10-0192 and the College of Pharmacy Research Center, King Saud University, Saudi Arabia.

Conflict of interest

There are no financial or other interests with regard to this manuscript that might be construed as a conflict of interest. All of the authors are aware of and agree to the content of the manuscript and their being listed as an author on the manuscript.

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, College of Pharmacology, King Saud University, P.O. Box 2457, Riyadh, 11451, Kingdom of Saudi Arabia

    Hesham Mohamed Korashy, Hani A. Al-Suwayeh, Zaid H. Maayah, Mushtaq Ahmad Ansari, Sheikh Fayaz Ahmad & Saleh A. Bakheet

Authors
  1. Hesham Mohamed Korashy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hani A. Al-Suwayeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zaid H. Maayah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mushtaq Ahmad Ansari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sheikh Fayaz Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Saleh A. Bakheet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hesham Mohamed Korashy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Korashy, H.M., Al-Suwayeh, H.A., Maayah, Z.H. et al. Mitogen-Activated Protein Kinases Pathways Mediate the Sunitinib-Induced Hypertrophy in Rat Cardiomyocyte H9c2 Cells. Cardiovasc Toxicol 15, 41–51 (2015). https://doi.org/10.1007/s12012-014-9266-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12012-014-9266-y

Keywords

Search

Navigation